http://www.aclaristx.com
Aclaris Therapeutics, Inc. Company Intro
Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our pipeline.
Industry
Healthcare
Aclaris Therapeutics, Inc. Headquaters
640 Lee Road
Wayne,19087
United States
Aclaris Therapeutics, Inc. Share price
17 May 2023 12:42 GMT
$8.19
-0.13 (-1.56 %)
Aclaris Therapeutics, Inc. Market cap
$607.468 M
WMC RANKING
2023
Aclaris Therapeutics, Inc. # 200
BiotechnologyLatest Aclaris Therapeutics, Inc. News
20 Sep 2023
Aclaris Therapeutics (NASDAQ:ACRS) Rating Reiterated by ...
Aclaris Therapeutics, Inc operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United...
20 Sep 2023
Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating ...
Aclaris Therapeutics, Inc operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United...
19 Sep 2023
Analyst Reiterates Buy Rating for Aclaris Therapeutics with ...
Aclaris Therapeutics Inc is a pharmaceutical company that specializes in developing innovative therapies for dermatological conditions. Their focus on cutting-...
WMC Market Score
WMC Market to Revenue Score
Aclaris Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aclaris Therapeutics, Inc. | USD | $6,852 | $51,049 | $-64,183 | $6,075M | 200 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aclaris Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Post vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aclaris Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Aclaris Therapeutics, Inc. | 0.07 | 2.53 | 0.00 | 0 | 0 | 0 | 1.09 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
